Advanced search
Publication Cover
Leukemia & Lymphoma Volume 12, 1994 - Issue 3-4
Submit an article Journal homepage
17
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Efficacy of Recombinant Human Erythropoietin in the Treatment of Refractory Anemias Without Excess of Blasts in Myelodysplastic Syndromes

Françoise Isnard Service des Maladies du Sang Hopital, Saint-Antoine, Paris
,
Myriam Labopin Service des Maladies du Sang Hopital, Saint-Antoine, Paris
,
Jean-Philippe Laporte Service des Maladies du Sang Hopital, Saint-Antoine, Paris
,
Norbert-Claude Gorin Service des Maladies du Sang Hopital, Saint-Antoine, Paris
,
Albert Najman Service des Maladies du Sang Hopital, Saint-Antoine, Paris; Laboratoire d'Etudes de rHematopoièse Faculté de Médecine, Saint-Antoine, Paris
,
Bernard Jaar Laboratoire d'Etudes de rHematopoièse Faculté de Médecine, Saint-Antoine, Paris
,
Claude Baillou Laboratoire d'Etudes de rHematopoièse Faculté de Médecine, Saint-Antoine, Paris
,
Elie Khoury Laboratoire d'Etudes de rHematopoièse Faculté de Médecine, Saint-Antoine, Paris
,
Pierre Fenaux Service des Maladies du Sang CHU de Lille, France
,
Martine Woler Boehringer Mannheim, France, France
&
Francis Bauters Service des Maladies du Sang CHU de Lille, France
 show all
Pages 307-314 | Received 20 May 1993, Published online: 01 Jul 2009

References

  • Prchal J.T., Trockmorton D.W., Carrol A.J., Fuson E.W., Gams R.A., Prchal J.F. A common progenitor for myeloid and lymphoid cells. Nature 1978; 274: 590–591
  • Raskind W.H., Tirumali N., Jacobson R., Singer J., Fialkow J. Evidence for a multistep pathogenesis of a myelodysplastic syndrome. Blood 1984; 63: 1318–1323
  • Adamson J.W., Eschbach J.W. Management of the anaemia of chronic renal failure with recombinant erythropoietin. Q. J. Med. 1989; 73: 1093–1101
  • Jacobs A., Janowska-Wieczorek J., Caro A., Bowen D.T., Lewis T. Circulating erythropoietin in pátients with myelodysplastic syndromes. Br. J. Haematol. 1989; 73: 36–39
  • Prchal J.F., Adamson J.W., Murphy S., Steinmann L., Fialkow P.J. Polycytemia vera: the in vitro response of normal and abnormal stem cell lines to erythropoietin. J. Clin. Invest. 1978; 61: 1044–1047
  • Cynshi O., Satoh K., Higuchi M., Imai N., Kawaguchi T., Hirashima K. Effects of recombinant human erythropoietin on anaemic W/Wv and SI/SId mice. Br. J. Haematol. 1990; 75: 319–324
  • McMahon G., Vragas R., Ryan M., Jain A.K., Abels R.I., Perry B., Smith I.L. Pharmacokinetics and effects of recombinant human erythropoietin after intravenous and subcutaneous injections in healthy volunteers. Blood 1990; 76: 1718–1722
  • Benett J.M., Catovski D., Daniel M.D., Flandrin G., Galton D.A.G., Gralnick H.R., Sultan C. Proposals for the classification of the myelodysplastic syndromes. Br. J. Haematol. 1982; 51: 189–199
  • Vadhan-Raj S., Keating M., Lemaistre A., Hittelman W.N., Mc Credie K., Trujillo J.M., Broxmeyer H.E., Hennecy C., Gutterman J.U. Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes. N. Eng. J. Med. 1987; 317: 1545–1552
  • Bowen D., Culligan D., Jacobs A. The treatment of anaemia in the myelodysplastic syndrome with recombinant human erythropoietin. Br. J. Haematol. 1991; 77: 419–423
  • Bessho M., Jinnal I., Matsuda A., Saito M., Kunitake H. Improvement of anemia by recombinant erythropoietin in patients with myelodysplastic syndromes and aplastic anemia. Int. J. Cell Cloning 1990; 8: 445–450
  • Schouten H.C., Vellenga E., Van Rhenen D.J., De Wolf J.T.M., Coppens P.J.M., Blijham G.H. Recombinant human erythropoietin in patients with myelodysplastic syndromes. Leukemia 1991; 5: 432–436
  • Stein R.S., Abels R.I., Krantz S.B. Pharmacological doses of recombinant human erythropoietin in the treatment of myelodysplastic syndromes. Blood 1991; 78: 1658–1663
  • Van Kamp H., Prinsze-Postema T.C., Kluin P.M., Den Ottolender G.J., Beverstock G.C., Willemze R., Fibbe W.E. Effect of subcutaneously administrated human recombinant erythropoietin on erythropoiesis in patients with myelodysplastia. Br. J. Haematol. 1991; 78: 488–493
  • Greenberg P.L. In vitro culture techniques defining biological abnormalities in the myelodysplastic syndromes and myeloproliferative disorders. Clin. Haematol. 1986; 15: 973–993
  • Dormer P., Schalhorn A., Wilmanns W., Hershko C. Erythroid and myeloid maturation patterns related to progenitor assessment in the myelodysplastic syndromes. Br. J. Haematol. 1987; 67: 61–66
  • Koury M.J., Bondurant M.C. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 1990; 248: 378–381

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.